Drug Shortage Report for SYNAREL
| Report ID | 127336 |
| Drug Identification Number | 02188783 |
| Brand name | SYNAREL |
| Common or Proper name | SYNAREL |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | NAFARELIN |
| Strength(s) | 200MCG |
| Dosage form(s) | METERED-DOSE AEROSOL |
| Route of administration | NASAL NASAL |
| Packaging size | 8ML |
| ATC code | H01CA |
| ATC description | HYPOTHALAMIC HORMONES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-10-26 |
| Estimated end date | 2020-11-27 |
| Actual end date | 2020-11-20 |
| Shortage status | Resolved |
| Updated date | 2020-11-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-10-28 | English | Compare |
| v2 | 2020-10-28 | French | Compare |
| v3 | 2020-11-23 | English | Compare |
| v4 | 2020-11-23 | French | Compare |
Showing 1 to 4 of 4